Indication: Betahistine is indicated for the treatment of vertigo, tinnitus, hearing loss and nausea associated with Meniere’s syndrome. Initial oral treatment is 8 mg to 16 mg three times daily, taken with food. Maintenance doses are generally in the range 24-48 mg daily.
PACKING: 20 X 1 X 10
PTR: 113.60
SHIPPER: 80
MRP: 1920.00
% GAIN: 1590.14
Similar Product: VERTIN 8
Elder Laboratories Ltd. Is a Pharmaceutical company engaged in Research & Development, Manufacturing, Marketing and sale of finished formulations across the world.
Copyright © 2022 All rights reserved.
